◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

KINIKSA PHARMACEUTICALS INTERNATIONAL, PLC

CIK: 1730430 SIC: 2834
$597.97M
Revenue
$35.92M
Net Income
87.52%
Gross Margin
6.38%
Op. Margin
$174.11M
Free Cash Flow
Financial Statements Quarterly (10-Q)
Showing 13 of 23 quarterly reports available
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
+ Total Revenue $180.85M $156.80M $137.78M $122.54M $112.21M $108.63M $79.86M $83.39M $67.05M $71.47M $48.34M $61.88M $99.14M
Revenue Growth % (YoY) 61.2% 44.3% 72.5% 46.9% 67.4% 52.0% 65.2% 34.8% -32.4% nan% nan% nan% nan%
Cost of Revenue $20.26M $18.60M $17.87M $17.90M $20.11M $12.32M $10.58M $9.58M $9.09M $7.70M $7.04M $6.71M $11.56M
+ Gross Profit $160.60M $138.19M $119.92M $104.64M $92.11M $96.31M $69.28M $73.81M $57.96M $63.77M $41.31M $55.17M $87.58M
Gross Margin % 88.8% 88.1% 87.0% 85.4% 82.1% 88.7% 86.7% 88.5% 86.4% 89.2% 85.4% 89.2% 88.3%
Research & Development $24.17M $18.75M $19.32M $35.22M $26.06M $24.02M $26.33M $20.05M $17.11M $23.77M $15.17M $14.39M $16.48M
Selling General & Admin $49.10M $46.86M $43.53M $40.53M $46.40M $42.40M $38.68M $36.74M $34.47M $29.18M $29.05M $27.21M $24.68M
+ Operating Income $24.02M $20.16M $13.27M $-19.30M $-9.66M $-117.00K $-16.54M $81.00K $-10.93M $-3.15M $-11.20M $6.05M $46.41M
Operating Margin % 13.3% 12.9% 9.6% -15.7% -8.6% -0.1% -20.7% 0.1% -16.3% -4.4% -23.2% 9.8% 46.8%
Interest Income - - - - - - - - - - - - $322.00K
Income Before Tax $27.16M $22.88M $15.56M $-16.98M $-7.20M $2.30M $-14.28M $2.45M $-8.50M $-1.24M $-9.36M $6.84M $46.73M
Income Tax Expense $8.72M $5.04M $7.03M $-8.09M $5.49M $6.21M $3.43M $-22.79M $5.36M $-16.21M $2.91M $2.38M $-177.36M
+ Net Income $18.43M $17.83M $8.54M $-8.89M $-12.69M $-3.91M $-17.70M $25.24M $-13.86M $14.97M $-12.27M $4.46M $224.09M
Net Margin % 10.2% 11.4% 6.2% -7.3% -11.3% -3.6% -22.2% 30.3% -20.7% 20.9% -25.4% 7.2% 226.0%
Basic EPS 0.25 0.24 0.12 -0.12 -0.18 -0.06 -0.25 0.36 -0.20 0.21 -0.18 0.06 3.23
Diluted EPS 0.23 0.23 0.11 -0.12 -0.18 -0.06 -0.25 0.36 -0.20 0.21 -0.18 0.05 3.18
Basic Shares Outstanding 74.7M 73.4M 72.6M 301K 71.7M 71.0M 70.6M 105K 70.2M 69.9M 69.8M 77K 69.4M
Diluted Shares Outstanding 80.0M 77.9M 76.1M 301K 71.7M 71.0M 70.6M 2.0M 70.2M 71.6M 69.8M 135K 70.6M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Cash & Cash Equivalents $174.86M $192.04M $157.13M $183.58M $97.38M $99.27M $141.08M $107.95M $117.83M $112.57M $80.62M $122.72M $175.76M
Short-term Investments $177.24M $115.75M $111.21M $60.05M $126.40M $119.49M $72.47M $98.42M $83.26M $72.42M $106.88M $67.89M $24.96M
Accounts Receivable $51.74M $31.91M $40.06M $41.72M $24.89M $20.45M $15.99M $21.27M $3.04M $24.65M $7.42M $12.66M $11.16M
Inventory $41.40M $48.18M $22.07M $26.36M $28.68M $34.86M $27.28M $31.12M $25.58M $23.96M $23.43M $21.60M $14.62M
Other Current Assets $30.29M $32.44M $25.43M $20.08M $33.95M $26.95M $13.77M $17.54M $26.40M $12.44M $13.16M $10.54M $15.31M
Total Current Assets $475.53M $420.31M $355.91M $331.80M $311.30M $301.02M $270.59M $276.30M $256.11M $246.04M $231.50M $243.06M $241.81M
Property Plant & Equipment $1.66M $1.08M $606.00K $662.00K $561.00K $625.00K $712.00K $734.00K $918.00K $1.14M $1.39M $1.66M $2.00M
Intangible Assets $15.50M $15.75M $16.00M $16.25M $16.50M $16.75M $17.00M $17.25M $17.50M $17.75M $18.00M $18.25M $18.50M
Other Non-current Assets $8.29M $8.20M $8.20M $10.31M $7.85M $7.90M $4.13M $827.00K $2.29M $2.35M $2.32M $5.82M $5.63M
Total Assets $712.33M $661.15M $599.33M $580.55M $555.30M $542.43M $519.67M $526.32M $483.06M $484.33M $442.86M $459.67M $459.95M
Accounts Payable $6.15M $8.96M $1.98M $2.04M $8.33M $7.39M $5.63M $8.25M $1.01M $648.00K $1.39M $7.90M $1.47M
Accrued Liabilities $30.94M $35.96M $22.13M $32.35M $40.38M $33.37M $44.72M $44.67M $41.15M $35.32M $20.89M $30.11M $30.87M
Deferred Revenue - - - - - $12.00K $156.00K $307.00K $2.56M $4.67M $6.50M - $12.09M
Other Current Liabilities $20.52M $18.00M $17.09M $16.08M $16.07M $11.48M $11.43M $8.19M $6.43M $4.60M $4.33M $5.75M $8.79M
Total Current Liabilities $123.59M $117.83M $97.27M $100.62M $95.95M $84.29M $64.21M $63.67M $53.47M $47.47M $36.59M $47.07M $56.49M
Other Non-current Liabilities $14.53M $9.26M $5.14M $1.82M $1.96M $1.93M $1.89M $1.86M $1.95M $1.92M $1.88M $1.84M $1.82M
Total Liabilities $176.95M $166.14M $141.84M $142.12M $118.29M $107.33M $87.78M $87.48M $77.94M $72.68M $52.77M $63.52M $75.94M
Retained Earnings $-476.34M $-494.77M $-512.60M $-521.14M $-512.25M $-499.56M $-495.65M $-477.95M $-503.19M $-489.33M $-504.30M $-492.03M $-496.50M
Total Stockholders Equity $535.38M $495.01M $457.49M $438.44M $437.01M $435.10M $431.89M $438.84M $405.13M $411.66M $390.10M $396.15M $384.01M
Total Liabilities & Equity $712.33M $661.15M $599.33M $580.55M $555.30M $542.43M $519.67M $526.32M $483.06M $484.33M $442.86M $459.67M $459.95M
Breakdown Q3 2025
(Sep 30, 2025)
Q2 2025
(Jun 30, 2025)
Q1 2025
(Mar 31, 2025)
Q4 2024
(Dec 31, 2024)
Q3 2024
(Sep 30, 2024)
Q2 2024
(Jun 30, 2024)
Q1 2024
(Mar 31, 2024)
Q4 2023
(Dec 31, 2023)
Q3 2023
(Sep 30, 2023)
Q2 2023
(Jun 30, 2023)
Q1 2023
(Mar 31, 2023)
Q4 2022
(Dec 31, 2022)
Q3 2022
(Sep 30, 2022)
Net Income $18.43M $26.37M $8.54M $-8.89M $-34.30M $-3.91M $-17.70M $25.24M $-11.15M $14.97M $-12.27M $4.46M $178.90M
Depreciation & Amortization $1.09M $703.00K $345.00K $400.00K $1.29M $896.00K $466.00K $540.00K $1.80M $1.20M $596.00K $602.00K $1.80M
Stock-based Compensation $10.14M $16.62M $7.75M $8.30M $22.39M $14.57M $7.21M $7.77M $19.38M $12.59M $6.12M $6.37M $18.75M
Deferred Income Tax $4.23M $5.64M $2.99M $-3.16M $11.29M $14.93M $4.37M $-25.71M $-8.08M $-18.37M $1.08M $348.00K $-185.84M
Change in Receivables $10.02M $-9.81M $-1.66M $16.84M $3.62M $-815.00K $-5.27M $18.23M $-9.62M $11.99M $-5.24M $1.50M $7.17M
Change in Inventory $15.03M $21.82M $-4.29M $-2.32M $-2.44M $3.74M $-3.84M $5.54M $3.98M $2.36M $1.83M $6.98M $10.95M
Change in Payables $4.26M $6.99M $62.00K $-6.28M $-22.00K $-933.00K $-2.66M $7.23M $-6.89M $-7.25M $-6.51M $6.43M $-399.00K
Operating Cash Flow $84.09M $50.41M $22.32M $18.77M $6.92M $9.15M $3.99M $4.33M $8.98M $-8.01M $-4.27M $-11.58M $17.38M
Capital Expenditure $935.00K $264.00K $99.00K $193.00K $84.00K $84.00K $84.00K $56.00K $74.00K $58.00K $24.00K $-32.00K $137.00K
Investing Cash Flow $-118.18M $-55.42M $-51.54M $65.29M $-27.62M $-21.27M $25.52M $-14.89M $-14.66M $-2.39M $-37.92M $-42.66M $34.58M
Financing Cash Flow $25.36M $13.47M $2.77M $2.14M $10.12M $3.44M $3.61M $695.00K $800.00K $248.00K $90.00K $1.19M $1.33M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $180.85M - $475.44M -
Cost of Revenue $20.26M - $56.73M -
Research & Development $24.17M - $62.24M -
Selling General & Admin $49.10M - $139.50M -
Operating Income $24.02M - $57.45M -
Income Before Tax $27.16M - $65.60M -
Income Tax Expense $8.72M - $20.79M -
Net Income $18.43M $-3.91M $44.81M -
Basic EPS 0.25 - 0.61 -
Diluted EPS 0.23 - 0.57 -
Basic Shares Outstanding $74.71M - $73.61M -
Diluted Shares Outstanding $80.04M - $78.03M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $174.86M $183.58M
Short-term Investments $177.24M $60.05M
Accounts Receivable $51.74M $41.72M
Inventory $41.40M $26.36M
Other Current Assets $30.29M $20.08M
Total Current Assets $475.53M $331.80M
Property Plant & Equipment $1.66M $662.00K
Intangible Assets $15.50M $16.25M
Other Non-current Assets $8.29M $10.31M
Total Assets $712.33M $580.55M
Accounts Payable $6.15M $2.04M
Accrued Liabilities $30.94M $32.35M
Other Current Liabilities $20.52M $16.08M
Total Current Liabilities $123.59M $100.62M
Other Non-current Liabilities $14.53M $1.82M
Total Liabilities $176.95M $142.12M
Retained Earnings $-476.34M $-521.14M
Total Stockholders Equity $535.38M $438.44M
Total Liabilities & Equity $712.33M $580.55M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $18.43M $-3.91M $44.81M -
Depreciation & Amortization - - $1.09M -
Stock-based Compensation $10.14M - $26.77M -
Deferred Income Tax $4.23M - $9.86M -
Change in Receivables - - $10.02M -
Change in Inventory - - $15.03M -
Change in Payables - - $4.26M -
Operating Cash Flow - - $84.09M -
Capital Expenditure - - $935.00K -
Investing Cash Flow - - $-118.18M -
Financing Cash Flow - - $25.36M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-Q filings.

Quarterly data represents single quarter results (Q1-Q4). Some items may show year-to-date values if quarterly breakdown is unavailable.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...